VentriPoint Diagnostics Ltd. VPTDF OTC · Healthcare · Canada
$0.05 +3.86% +$0.00
Summary
36 / 100 · Bulios Score
What speaks for it
- Revenue grew by 38% a year over the last 3 years.
- It earns 193 CAD a year on every 100 CAD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- For every 100 CAD of bills due within a year it has 12 CAD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
Diluted EPS (CAD)
Revenue grew by 38% a year over 5 years. Over the last 3 years it grew by 38% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $2.32M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.